Large-scale implementation of an optimum technology for high-productivity processes with recombinant methylotrophic yeasts
Public support
Provider
Ministry of Education, Youth and Sports
Programme
Programme of regional and international cooperation in R&D (National programme of research)
Call for proposals
Regionální a mezinárodní spolupráce ve výzkumu 2 (SMSM2004001P2)
Main participants
—
Contest type
VS - Public tender
Contract ID
11064/2004-32
Alternative language
Project name in Czech
Optimalizace a zavedení technologie vysoce produkčních procesů využívajících rekombinantních methylotrofních kvasinek do průmyslového měřítka
Annotation in Czech
inovační stabilní proces kultivace rekombinantní kvasinky Pichia pastoris, stabilní technologie kultivace, produkce rekombinantního proteinu
Scientific branches
R&D category
NV - Nonindustrial research (Applied research excluded Industrial research)
CEP classification - main branch
EI - Biotechnology and bionics
CEP - secondary branch
—
CEP - another secondary branch
—
OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)
20801 - Environmental biotechnology<br>20802 - Bioremediation, diagnostic biotechnologies (DNA chips and biosensing devices) in environmental management<br>20803 - Environmental biotechnology related ethics<br>20901 - Industrial biotechnology<br>20902 - Bioprocessing technologies (industrial processes relying on biological agents to drive the process) biocatalysis, fermentation<br>20903 - Bioproducts (products that are manufactured using biological material as feedstock) biomaterials, bioplastics, biofuels, bioderived bulk and fine chemicals, bio-derived novel materials<br>30401 - Health-related biotechnology<br>30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)<br>30403 - Technologies involving identifying the functioning of DNA, proteins and enzymes and how they influence the onset of disease and maintenance of well-being (gene-based diagnostics and therapeutic interventions [pharmacogenomics, gene-based therapeutics])<br>30404 - Biomaterials (as related to medical implants, devices, sensors)<br>30405 - Medical biotechnology related ethics<br>40401 - Agricultural biotechnology and food biotechnology<br>40402 - GM technology (crops and livestock), livestock cloning, marker assisted selection, diagnostics (DNA chips and biosensing devices for the early/accurate detection of diseases) biomass feedstock production technologies, biopharming<br>40403 - Agricultural biotechnology related ethics
Completed project evaluation
Provider evaluation
U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)
Project results evaluation
A novell process strategy for recombinant protein production employing expression systém. It was implemented into Lonza Biotec
Solution timeline
Realization period - beginning
Jan 1, 2005
Realization period - end
Oct 31, 2007
Project status
U - Finished project
Latest support payment
Mar 16, 2007
Data delivery to CEP
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data delivery code
CEP08-MSM-1P-U/01:1
Data delivery date
Jun 26, 2008
Finance
Total approved costs
4,645 thou. CZK
Public financial support
2,776 thou. CZK
Other public sources
0 thou. CZK
Non public and foreign sources
1,549 thou. CZK